{"id":"neither-pregabalin-nor-gabapentin","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dizziness"},{"rate":"5-10%","effect":"Somnolence"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Dry mouth"},{"rate":"5-10%","effect":"Weight gain"},{"rate":"5-10%","effect":"Edema"},{"rate":"5-10%","effect":"Arthralgia"},{"rate":"5-10%","effect":"Muscle weakness"}]},"_chembl":{"chemblId":"CHEMBL1059","moleculeType":"Small molecule","molecularWeight":"159.23"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Pain medications like this one work by blocking the flow of calcium ions into nerve cells, which reduces the release of pain-causing chemicals. This leads to a decrease in the transmission of pain signals to the brain.","oneSentence":"It works by binding to voltage-gated calcium channels in the nervous system, reducing the release of pain-causing chemicals.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:34:50.698Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Neuropathic pain"},{"name":"Fibromyalgia"}]},"trialDetails":[{"nctId":"NCT04705480","phase":"PHASE4","title":"Pregabalin vs. Gabapentin on Reducing Opioid Usage","status":"COMPLETED","sponsor":"CAMC Health System","startDate":"2021-04-12","conditions":"Analgesics, Gabapentin, Injuries","enrollment":109}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1762,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Neither Pregabalin nor Gabapentin","genericName":"Neither Pregabalin nor Gabapentin","companyName":"CAMC Health System","companyId":"camc-health-system","modality":"Small molecule","firstApprovalDate":"","aiSummary":"It works by binding to voltage-gated calcium channels in the nervous system, reducing the release of pain-causing chemicals. Used for Neuropathic pain, Fibromyalgia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}